L vs TERN · P/E 14, rev $18.45B vs $6.12B cap
Loews Corp (L) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
L currently screens at market cap $22.36B and trailing P/E 13.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the L and TERN stock pages for the full models.
Not investment advice.